Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gossamer Bio (GOSS) Return on Equity (2022 - 2025)

Gossamer Bio's Return on Equity history spans 4 years, with the latest figure at 1.69% for Q4 2025.

  • For Q4 2025, Return on Equity rose 311.0% year-over-year to 1.69%; the TTM value through Dec 2025 reached 1.69%, up 311.0%, while the annual FY2025 figure was 3.65%, 488.0% up from the prior year.
  • Return on Equity reached 1.69% in Q4 2025 per GOSS's latest filing, down from 2.47% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 27.37% in Q1 2023 to a low of 9.11% in Q3 2023.
  • Average Return on Equity over 4 years is 0.84%, with a median of 1.42% recorded in 2024.
  • The largest YoY upside for Return on Equity was 802bps in 2024 against a maximum downside of -3129bps in 2024.
  • A 4-year view of Return on Equity shows it stood at 6.75% in 2022, then surged by 68bps to 2.17% in 2023, then surged by 35bps to 1.42% in 2024, then skyrocketed by 219bps to 1.69% in 2025.
  • Per Business Quant, the three most recent readings for GOSS's Return on Equity are 1.69% (Q4 2025), 2.47% (Q3 2025), and 5.4% (Q2 2025).